The first batch of the South Korean analogue of Botox, Novacutan-BTA from Huons Global, was released into circulation in Russia. The original drug disappeared from the Russian market due to the cessation of Allergan’s activities in the country.
According to RNC Pharma, after the departure of the original drug, the botulinum toxin market quickly restructured. The French “Dysport” from Ipsen became the market leader – its sales increased by almost 80% over the year.
South Korean botulinum toxin appeared on the Russian market for the first time. Huons Global also supplies the drug to Ecuador, the Dominican Republic, Iraq, Bolivia, Georgia and a number of CIS countries.
